Serum Institute of India gets DCGI permission to restart phase 2, 3 trials of coronavirus COVID-19 vaccine - Comprehensive, up-to-date news coverage, aggregated from sources all over the world ,

Comprehensive, up-to-date news coverage, aggregated from sources all over the world ,

अंतर्राष्ट्रीय, बॉलीवुड, खेल समाचार ,. ताज़ी खबरें. ट्रेंडिंग न्यूज़. शैलियां: અમદાવાદ, સુરત, વાઇરલ. राष्ट्रीय समाचार आज की राशि फिल्मी दुनिया की खबरें खेल की खबरेंRead latest Politics & Current Affairs in India & around the World at Times Now! English News. Expert Opinion. Videos & Photos. Hindi News. Watch Live TV. Types: Politics, Finance, Sports. Breaking India News Sports News & Headlines News - Breaking News, Latest News & Top Video News

Breaking

Home Top Ad

Post Top Ad

Tuesday, 15 September 2020

Serum Institute of India gets DCGI permission to restart phase 2, 3 trials of coronavirus COVID-19 vaccine

The Serum Institute of India (SII) is all set to restart its phase two and three clinical trials for the COVID-19 vaccine after getting the nod from the Drugs Controller General of India (DCGI).

from Zee News :India National https://ift.tt/3kn5P8o
via IFTTT

No comments:

Post a Comment

Post Bottom Ad

Pages